Reply to “A call for reporting of tumor‐specific outcomes in studies of <i>DPYD</i> genotyping”-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reply to “A call for reporting of tumor‐specific outcomes in studies of DPYD genotyping”

Published:2024-08 Issue:8 Volume:17 Page:
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical Translational Sci

Author:

El Rouby Nihal¹²^ORCID,Allen Josiah D.¹,Muldoon Megan³,Beck Mollie¹,Hesse Kristina¹,Sebree Nichlas⁴,Yoder Robin¹,Ritter Stacey¹,Alqahtani Zuhair²,Grund Jaime¹,Holbrook Brooke Philips¹

Affiliation:

1. St Elizabeth Healthcare Edgewood Kentucky USA

2. Department of Pharmacy Practice and Administrative Sciences, James L Winkle College of Pharmacy University of Cincinnati Cincinnati Ohio USA

3. Swedish Hospital, Part of Endeavor Health Chicago Illinois USA

4. University of Cincinnati Medical Center Cincinnati Ohio USA

Publisher

Wiley

Link

https://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1111/cts.70008

Reference5 articles.

1. Real‐world implementation of DPYD and UGT1A1 pharmacogenetic testing in a community‐based cancer center

2. Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy

3. Pathogenic DPYD Variants and Treatment-Related Mortality in Patients Receiving Fluoropyrimidine Chemotherapy: A Systematic Review and Meta-Analysis

4. DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis

5. Survival of Patients With Cancer With DPYD Variant Alleles and Dose-Individualized Fluoropyrimidine Therapy—A Matched-Pair Analysis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP